Relmada Therapeutics Inc (RLMD)

NASDAQ
4.27
-0.03(-0.70%)
After Hours
4.27
0.00(0.00%)
- Real-time Data
  • Volume:
    291,366
  • Day's Range:
    4.20 - 4.47
  • 52 wk Range:
    1.81 - 38.68

RLMD Overview

Prev. Close
4.3
Day's Range
4.2-4.47
Revenue
-
Open
4.43
52 wk Range
1.81-38.68
EPS
-5.71
Volume
291,366
Market Cap
128.52M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
777,883
P/E Ratio
-0.74
Beta
-0.013
1-Year Change
-75.12%
Shares Outstanding
30,099,203
Next Earnings Date
Mar 22, 2023
What is your sentiment on Relmada Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Relmada Therapeutics Inc News

Relmada Therapeutics Inc Analysis

Relmada Therapeutics Inc Company Profile

Relmada Therapeutics Inc Company Profile

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), which is an N-methyl-D-aspartate (NMDA) receptor antagonist. The Company’s lead product candidate, esmethadone, is a new chemical entity (NCE) developed as a rapidly acting, oral agent for the treatment of depression, central nervous system (CNS) diseases and other potential indications. The Company’s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission and is in development for both the adjunctive or monotherapy treatment of major depressive disorder (MDD).

Read More

Analyst Price Target

Average13.38 (+213.23% Upside)
High34.00
Low3.00
Price4.27
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong SellBuyNeutralStrong Sell
SummaryNeutralNeutralBuyNeutralStrong Sell
  • up
    1